Levonorgestrel (Emergency Contraception)
Brand names: Levonelle 1500, Upostelle, Ezinelle
Levonorgestrel is a progestogen used as emergency contraception after unprotected sex or contraceptive failure. It is effective when taken up to 72 hours afterwards, and the sooner it is taken the more effective it is.
Adult dose
Dose auto-extracted from UK Summary of Product Characteristics (SPC) via the eMC — not yet clinician-verified. Always confirm against the product SmPC and your local formulary before prescribing.
Contraindications
- Hypersensitivity to the active substance or to any of the excipients (§4.3)
- Not recommended in patients at risk of ectopic pregnancy (previous history of salpingitis or of ectopic pregnancy) (§4.4)
- Not recommended in patients with severe hepatic dysfunction (§4.4)
- Contains lactose monohydrate - patients with rare hereditary problems of galactose intolerance, total lactase deficiency or glucose-galactose malabsorption should not take this medicine (§4.4)
Side effects
- Nausea (very common) - the most commonly reported undesirable effect; lower abdominal pain (very common)
- Headache (very common); dizziness (common)
- Bleeding not related to menses (very common) - patterns may be temporarily disturbed but most women will have their next period within 5-7 days of the expected time
- Delay of menses more than 7 days (very common); irregular menstruation (common)
- Fatigue (very common); breast tenderness (common); diarrhoea and vomiting (common)
Interactions
- Enzyme-inducing drugs used within the last 4 weeks - a non-hormonal emergency contraceptive (Cu-IUD) is recommended, or a double dose of levonorgestrel (2 tablets taken together) for women unable or unwilling to use a Cu-IUD (§4.2)
- Severe malabsorption syndromes such as Crohn's disease might impair the efficacy of levonorgestrel (§4.4)
- NOTE: SPC §4.5 was truncated in the fetched source ('The metabolism of ...') - the full interactions section still needs to be reviewed
Clinical monograph
How it works
It works mainly by delaying or inhibiting ovulation; it is not an abortifacient and does not disrupt an established pregnancy.
Prescribing in practice
- It does not provide ongoing contraception for the rest of the cycle, so reliable contraception must be continued or started.
- A larger dose or an alternative (ulipristal acetate or a copper intrauterine device) may be advised at higher body weight or after enzyme-inducing drugs.
- It can be used more than once in a cycle if needed, but a copper intrauterine device is the most effective emergency option.
Monitoring
No routine monitoring is required; advise a pregnancy test if the next period is more than a few days late or is unusually light, and arrange ongoing contraception.
Counselling the patient
- Take it as soon as you can after unprotected sex, as it works better the earlier it is taken.
- If you vomit within a couple of hours of the dose, seek advice as you may need to repeat it.
- Use condoms or abstain until you start or restart reliable contraception, and do a pregnancy test if your period is late.
Evidence & guidelines
Recommended emergency contraceptive option (FSRH; NICE CKS).
Reference: FSRH Emergency Contraception Guideline 2017 (updated 2023); NICE; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. The structured dose values shown have been reviewed by a clinician. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- EDACS — Emergency Department Assessment of Chest Pain · Chest Pain
- San Francisco Syncope Rule · Syncope
- ROSE Rule for Syncope · Syncope
- Ottawa Heart Failure Risk Scale · Heart Failure
- Aortic Dissection Detection Risk Score (ADD-RS) · Aortic Disease
- Emergency Heart Failure Mortality Risk Grade (EHMRG) · Heart Failure
- Diabetic Ketoacidosis (DKA) · JBDS 2013 / Joint British Diabetes Societies; NICE NG17
- Adult Hypoglycaemia (Treated Diabetes) · JBDS-IP (2023): Hospital Management of Hypoglycaemia
- Adrenal Crisis · Society for Endocrinology Emergency Guidance (2024)
- Type 2 Diabetes Management · NICE NG28 2022
- Hyperthyroidism Management · BTA / ETA 2018
- Adrenal Insufficiency · Society of Endocrinology / ESE 2016